| NOBEL Pharma Schweiz AG - Rivaroxaban NOBEL 15 mg, Filmtabletten | | 68009 | | 02 | | Rivaroxaban NOBEL 15 mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 28.04.2022 | | |
| | Composition | | rivaroxabanum 15 mg, mannitolum, carmellosum natricum conexum, hypromellosum, natrii laurilsulfas, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, macrogolum 3350, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.3292 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Rivaroxabanum | 15 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 3350 | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Laurilsulfas | | | | Pro Compresso Obducto | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 14 | | | B | | Yes | | 005 | 28 | | | B | | Yes | | 006 | 98 | | | B | | Yes |
|
|
